XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-based Compensation (Tables)
3 Months Ended
Sep. 30, 2014
Share-based Compensation  
Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense

 

 

September 30,
2014

 

September 30,
2013

 

Risk-free interest rate

 

1.7 

%

2.1 

%

Expected volatility

 

52.1 

%

62.9 

%

Expected dividend yield

 

0.0 

%

0.0 

%

Forfeiture rate

 

6.5 

%

7.5 

%

Expected term (in years)

 

5.5 years

 

5.9 years

 

Weighted average fair value

 

$
16.82 

 

$
8.09 

 

 

Summary of stock option award activity

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted-

 

 

 

Average

 

 

 

 

 

Average

 

Aggregate

 

Remaining

 

 

 

 

 

Exercise

 

Intrinsic

 

Contractual

 

(In thousands, except for weighted average price and life data)

 

Awards

 

Price

 

Value

 

Life (yrs.)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at July 1, 2014

 

2,205

 

$

7.84

 

 

 

 

 

Granted

 

432

 

$

34.79

 

 

 

 

 

Exercised

 

(67

)

$

7.59

 

$

2,120

 

 

 

Forfeited, expired or repurchased

 

(1

)

$

16.19

 

 

 

 

 

Outstanding at September 30, 2014

 

2,569

 

$

12.38

 

$

85,565

 

7.6

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2014

 

2,451

 

$

11.93

 

$

82,704

 

7.5

 

Exercisable at September 30, 2014

 

1,277

 

$

6.36

 

$

50,208

 

6.1

 

 

Summary of nonvested restricted stock awards

(In thousands, except for weighted average price data)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

 

 

 

 

 

 

 

 

Non-vested at July 1, 2014

 

15

 

34.66

 

 

 

Granted

 

98

 

36.77

 

 

 

Vested

 

(9

)

36.77

 

$

345

 

Forfeited

 

(1

)

36.77

 

 

 

Non-vested at September 30, 2014

 

103

 

$

36.47

 

 

 

 

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

 

 

Three Months Ended
September 30,

 

(In thousands)

 

2014

 

2013

 

Selling, general and administrative

 

$

1,359 

 

$

809 

 

Research and development

 

120 

 

38 

 

Cost of sales

 

168 

 

50 

 

Total

 

$

1,647 

 

$

897 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

570 

 

$

102